MEDICATED WEIGHT LOSS
Mounjaro
How it works: GIP and GLP-1 receptor agonists suppress appetite, reduce cravings, and improve blood sugar levels
Effectiveness: Drives an average of 21% body weight reduction¹
Prices from:£229.00£135.00 / month
Mounjaro enhances your body's natural insulin response and slows down gastric emptying by imitating GLP-1 and GIP hormones. This not only helps in reducing hunger but also minimises food cravings.1
Implementing behavioural change strategies alongside the treatment is known to be an effective method for weight loss.1
Tirzepatide, the active ingredient in Mounjaro, has gone through several trials that highlight its effects on people who are overweight and obese.1,2
Alongside healthy habits, the treatment has demonstrated significant efficacy and safety in comprehensive clinical trials.1,2 It’s been approved by NICE and MHRA for weight loss since late 2023.3,4
Keeps you full between meals
Reduce cravings for dairy, savoury, sweet, and high-fat foods
Non-addictive
Easy to administer
At Numan, our Weight Loss Programme is crafted by a team of dedicated experts in the fields of obesity management, behavioural change, and metabolic health.
With treatments like Mounjaro, which combines GLP-1 and GIP receptor agonists to suppress appetite and improve blood sugar regulation, our experts have designed a holistic programme that pairs advanced medications with personalised health guidance for maximum impact.
From nutritionists to behavioural psychologists, each expert brings a unique perspective to enhance your journey and help you lose weight effectively and sustainably.
Health coaching is the backbone of lasting change in our programme. Alongside Mounjaro, our health coaches are here to support you in building sustainable habits in nutrition, exercise, sleep, and mindset.
While Mounjaro suppresses hunger and reduces food cravings, our coaches help you optimise these effects by guiding you toward a balanced lifestyle. From tips on satisfying, nutritious meals that to creative ways to integrate movement into your day, our coaches are committed to helping you unlock the full potential of your treatment.
At Numan, we treat obesity not simply as a symptom but as a complex, chronic disease influenced by factors like genetics, hormones, and environment.5 Our approach recognises that effective treatment requires more than lifestyle changes alone - it demands a targeted medical response.
Mounjaro plays a critical role in this treatment plan by helping to reduce appetite and regulate blood sugar levels, making it easier to maintain a balanced diet and achieve weight loss goals. By addressing obesity as a disease, we’re able to support you with an evidence-backed, compassionate approach that integrates effective treatment, expert support, and personalised coaching.
1 Based on tirzepatide 15mg over 72 weeks. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & the SURMOUNT-1 Investigators. Tirzepatide once weekly for the treatment of obesity. The New England Journal of Medicine (2022)
2 Aronne, L. J., Sattar, N., Horn, D. B., Bays, H. E., Wharton, S., Lin, W. Y., Ahmad, N. N., Zhang, S., Liao, R., Bunck, M. C., Jouravskaya, I., Murphy, M. A., & SURMOUNT-4 Investigators (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA, 331(1), 38–48. https://doi.org/10.1001/jama.2023.24945
3 National Institute for Health and Care Excellence (NICE). (2024). Tirzepatide for managing overweight and obesity [ID6179]. Retrieved December 6, 2024, from https://www.nice.org.uk/guidance/ta6179
4 Medicines and Healthcare products Regulatory Agency (MHRA). (2023, November 8). MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss. Retrieved December 6, 2024, from https://www.gov.uk/government/news/mhra-authorises-diabetes-drug-mounjaro-tirzepatide-for-weight-management-and-weight-loss
5 Lee A, Cardel M, Donahoo WT. Social and Environmental Factors Influencing Obesity. [Updated 2019 Oct 12]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK278977/
Answer a few simple questions to get the treatment you need.